The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: -108.00 (-0.87%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Goldman Sachs Cuts Next To Neutral From Buy

Mon, 11th May 2020 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

GOLDMAN SACHS CUTS NEXT TO 'NEUTRAL' ('BUY') - PRICE TARGET 5300 PENCE

----------

JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 8,000 (7,575) PENCE - 'HOLD'

----------

BRYAN GARNIER RAISES ASTRAZENECA PRICE TARGET TO 8,780 (8,550) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS EASYJET PRICE TARGET TO 746 (945) PENCE - 'OUTPERFORM

----------

MORGAN STANLEY CUTS LAND SECURITIES PRICE TARGET TO 740 (880) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS BRITISH LAND PRICE TARGET TO 450 (540) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES SEGRO PRICE TARGET TO 980 (950) PENCE - 'OVERWEIGHT'

----------

HSBC RAISES CARNIVAL TO 'BUY' ('HOLD') - TARGET 1280 (3500) PENCE

----------

BERENBERG RAISES OCADO PRICE TARGET TO 2225 (1725) PENCE - 'BUY'

----------

BERENBERG RAISES ST JAMES'S PLACE PRICE TARGET TO 875 (830) PENCE - 'HOLD'

----------

JPMORGAN CUTS RIO TINTO PRICE TARGET TO 4560 (4730) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS BHP GROUP PRICE TARGET TO 1780 (1830) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS ROLLS-ROYCE PRICE TARGET TO 155 (175) PENCE - 'UNDERWEIGHT'

----------

FTSE 250

----------

MORGAN STANLEY CUTS HAMMERSON TO 'UNDERWEIGHT' ('EQUAL-WEIGHT') - TARGET 50 (175) PENCE

----------

MORGAN STANLEY RAISES LONDONMETRIC PROPERTY TO 'EQUAL-WEIGHT' ('UNDERWEIGHT') - TARGET 200 (210) PENCE

----------

MORGAN STANLEY CUTS SHAFTESBURY PRICE TARGET TO 610 (770) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS GREAT PORTLAND PRICE TARGET TO 720 (920) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS DERWENT LONDON PRICE TARGET TO 3400 (4250) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS BIG YELLOW GROUP PRICE TARGET TO 900 (1000) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES IMI PRICE TARGET TO 980 (940) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS UNITE GROUP PRICE TARGET TO 950 (1300) PENCE - 'OVERWEIGHT'

----------

UBS RAISES TRAVIS PERKINS PRICE TARGET TO 1070 (1040) PENCE - 'NEUTRAL'

----------

HSBC CUTS WEIR GROUP TO 'HOLD' ('BUY') - TARGET 985 (1045) PENCE

----------

JPMORGAN CUTS BODYCOTE PRICE TARGET TO 530 (615) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS TATE & LYLE PRICE TARGET TO 740 (770) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

BERNSTEIN RAISES BOOHOO TO 'OUTPERFORM' ('MARKET-PERFORM') - TARGET 415 PENCE

----------

BERENBERG CUTS AA PRICE TARGET TO 20 (30) PENCE - 'SELL'

----------

BERENBERG RAISES BURFORD CAPITAL PRICE TARGET TO 820 (810) PENCE - 'BUY'

----------

RBC CUTS SPIRE HEALTHCARE TO 'SECTOR PERFORM' ('OUTPERFORM') - TARGET 100 PENCE

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more
9 Nov 2023 09:23

TOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drug

(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu.

Read more
9 Nov 2023 08:57

LONDON MARKET OPEN: FTSE 100 kicks off day with cautious gain

(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade.

Read more
9 Nov 2023 07:48

LONDON BRIEFING: AstraZeneca ups outlook but S4 Capital cuts

(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood.

Read more
9 Nov 2023 07:18

AstraZeneca hikes guidance after strong third quarter

(Sharecast News) - AstraZeneca released its financial results for the third quarter and first nine months of 2023 on Thursday, hiking its full-year guidance on the back of a robust performance and momentum in several segments.

Read more
3 Nov 2023 17:06

AstraZeneca plans next phase of trial on kidney drug combination data

(Alliance News) - AstraZeneca PLC on Friday touted results from a Phase IIb trial, which showed that a zibotentan and dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.